UnitedHealthcare served 1.6 million more people domestically in Q1 2024 compared to Q1 2023, driven by growth in commercial and Medicare offerings.

Optum Health experienced revenue growth, primarily due to organic growth in patients served under value-based care arrangements. Optum Health served approximately 104 million people as of March 31, 2024, compared to 103 million as of March 31, 2023.

Optum Rx experienced revenue and earnings from operations growth due to higher script volumes from both new clients and growth in existing clients, as well as growth in pharmacy services. Optum Rx fulfilled 395 million adjusted scripts in Q1 2024, compared to 378 million in Q1 2023.

Management took steps to mitigate the impact of the Change Healthcare cyberattack, including accelerating funding and providing interest-free loans to care providers. However, the cyberattack negatively impacted medical costs and Optum Insight's earnings from operations.

Operating cost management initiatives contributed to a decrease in the operating cost ratio, demonstrating management's focus on efficiency.

The company completed the sale of its Brazil operations in Q1 2024, resulting in a $7.1 billion loss, which impacted overall financial performance.

The cyberattack on Change Healthcare poses significant risks, including potential litigation, reputational harm, regulatory actions, and the release of protected health information (PHI) or personally identifiable information (PII).

Medicare Advantage rate notices have resulted in industry base rate decreases, creating continued pressure in the Medicare Advantage program. Substantial revisions to the risk adjustment model will result in reduced funding and potentially benefits for people.

Medicaid redeterminations are impacting the number of people served through Medicaid offerings, although this is partially offset by increased enrollment in commercial offerings.

The commercial risk market remains highly competitive, and the company expects broad-based competition to continue.

The company's cost management initiatives contributed to a decrease in the operating cost ratio, suggesting improved operational efficiency.

Optum Insight experienced revenue growth driven by technology services, indicating continued investment and innovation in this area.

The company repurchased approximately 6 million shares in Q1 2024 at an average price of $505.46 per share.

The company maintained its quarterly cash dividend to shareholders, reflecting an annual rate of $7.52.

As of March 31, 2024, the company has agreements to acquire companies in the health care sector for approximately $4 billion, subject to regulatory approval and other closing conditions.

The company expects overall spending on healthcare to continue to grow due to factors such as inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends, and national interest in health and well-being.